Language

Chinese English

Conference Information

Home page

Chinese Pharmaceutical Companies “Challenge” the World’s Most Expensive

Mar 24,2026

Full-Scale Pursuit

The Inaugural CNS Innovative Drug R&D Conference Is Here | CPIC Global Conference

Mar 23,2026

As the inaugural featured conference, The 1st CNS Innovative Drug R&D Conference is co-hosted by TONACEA, Hanshu Bio, and Quark Pharma. Focusing on the high-value, high-potential sector of CNS drug development, the conference brings together top R&D experts from around the world to decode emerging CNS targets and mechanisms, clinical development, gene editing, and other key technologies. It will feature in-depth discussions on cutting-edge topics such as the treatment of CNS diseases and global registration strategies for innovative drugs, aiming to establish a professional exchange platform for R&D innovation, clinical translation, industrial collaboration, and global partnership in the CNS field.

Blueprint for the Conference Unveiled! The Inaugural Global Summit on Innovative Drugs from Major Countries to Create a Chinese Version of JPM

Mar 22,2026

The conference is benchmarked against the J.P. Morgan Healthcare Conference, establishing a model of "China Innovation—Global Translation—Shanghai Exchange." It aims to highlight China's status as a major player in new drugs and drive Chinese innovation to lead the global health industry.

Zhu Xun: It’s Time for China’s Innovative Drugs to Shift from “R&D Stories” to “Profit Stories”

Mar 21,2026

The logic, challenges, and ways to break through the frenzy of going out to sea

The Chinese GLP-1 market is about to undergo a major shift.

Mar 20,2026

Semaglutide patent expiration

Dr. Zhang Dan Appointed Chief Scientist of PUMCH Innovation Harbor

Mar 18,2026

On February 2, 2026, the Inaugural Ceremony of the PUMC Innovation Hub at the Chinese Academy of Medical Sciences and Peking Union Medical College was held. The event was attended by nearly 200 guests, including diplomatic envoys accredited to China, representatives from the Ministry of Science and Technology, the National Health Commission, and relevant departments of the Beijing Municipal Government, leaders of the CPC Dongcheng District Committee and the Dongcheng District People’s Government, university leaders, academicians and expert representatives, heads of various institutes and research centers, as well as representatives from medical institutions, universities, industry associations, central and municipally owned enterprises, and partner organizations.

Set for July 22–24: The Inaugural Global Conference on Innovative Drugs of Major Countries (CPIC) is Positioned as the “Clover”

Mar 15,2026

Over the past decade, China’s innovative pharmaceutical industry has risen rapidly and become deeply integrated into the global pharmaceutical landscape, emerging as a top priority for multinational pharmaceutical companies in their pipeline strategies. In both quantity and quality, China’s innovative drugs are fully commensurate with the country’s status as a major power. Moreover, the thriving biopharmaceutical sector has, for the first time, been officially designated by the state as an “emerging pillar industry.”

In Vivo CAR-T: “Saturation-Driven Innovation” After One Year

Mar 14,2026

The blind box is about to be opened

< 1...17 18 19 20 > proceed page

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Public Account QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.